期刊文献+

核医学分子影像探针应用于神经内分泌肿瘤的研究进展 被引量:5

Application of molecular probes in nuclear imaging of neuroendocrine tumors
下载PDF
导出
摘要 神经内分泌肿瘤起源于神经嵴来源的神经内分泌细胞,可分泌多种胺和多肽激素进入全身循环。核医学分子影像探针在神经内分泌肿瘤的早期诊断、临床分期、治疗方案选择、复发和转移病灶的探查中具有重要意义,临床可根据神经内分泌肿瘤细胞增殖及分化程度、细胞表面的分子表达、肿瘤部位选择分子影像探针进行个体化显像。本文就葡萄糖类似物显像剂、生长抑素类似物显像剂、胺前体类显像剂、激素类似物显像剂和酶抑制剂类显像剂等核医学分子影像探针在神经内分泌肿瘤诊断和治疗中的发展及应用进行综述。 Neuroendocrine tumors are a type of heterogeneous tumors originating from neuroendocrine cells derived from the neural crest,which can secrete a variety of amines and peptide hormones.Based on different molecular biomarkers,histologic types and differentiation degrees,individualized nuclear imaging can provide information for the early diagnosis,clinical staging,treatment guidance,and detection of the recurrence and metastasis of neuroendocrine tumor.In this paper,we review the development and application of nuclear medicine molecular imaging probes such as glucose analogs,somatostatin analogues,amine precursors,hormone analogs and enzyme inhibitors in the diagnosis and treatment of neuroendocrine tumors.
作者 颜京 张婷婷 赵葵 YAN Jing;ZHANG Tingting;ZHAO Kui(Department of PET,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China)
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2021年第1期131-137,共7页 Journal of Zhejiang University(Medical Sciences)
关键词 神经内分泌肿瘤 诊断 分子探针 核医学显像 综述 Neuroendocrine tumors Diagnosis Molecular probe Nuclear medicine imaging Review
  • 相关文献

参考文献3

二级参考文献27

  • 1CHITI A, FANTI S, SAVELLI G, et al. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastm-entero-pancreatic tumours [ J ]. Eur J Nucl Med, 1998, 25(10) : 1396-1403.
  • 2MAXWELL J E, HOWE J R. Imaging in neuroendocrine tumors: an update for the clinician [J]. Int J Endocr Oneol, 2015, 2(2) :159-168.
  • 3WUW, CHEN M H, YIN S S, et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy [ J ]. AIR Am J Roentgenol, 2006, 187(3) : 752-761.
  • 4DORFFEL Y, WERMKE W. Neuroendocrine tumors:characterization with contrast-enhanced uhrasonography [J]. Ultraschall Med, 2008, 29(5) : 506-514.
  • 5CHANG K J. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors[J]. Endoscopy, 2006, 38: $56-$60.
  • 6KANN P H, BALAKINA E, IVAN D, et al. Natural course of small, asymptomatie neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study [ J ]. Endocr Relat Cancer, 2006, 13(4) : 1195-1202.
  • 7HOEFFEL C, JOB L, LADAM-MARCUS V, et al. Detection of hepatic metastases from carcinoid tumor: prospective evaluation of contrast-enhanced uhrasonography [ J ]. Dig Dis Sci, 2009, 54 ( 9 ) : 2040 -2046.
  • 8ISHIKAWA T, ITOH A, KAWASHIMA H, et al. Usefulness of EUS combined with contrast- enhancement in the differentia/ diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors [ J ]- Gastrointest Enclose, 2010, 71(6) : 951-959.
  • 9BUSHNELL D L, BAUM R P. Standard imaging techniques for neuroendoerine tumors [ J ]. Endocrinol Metab Clin North Am, 2011, 40(1) : 153-162.
  • 10SUNDIN A, VULLIERME M P, KALTSAS G, et al. ENETS consensus guidelines for the standards of care in neuroendoerine tumors: radiological examinations [J]. Neuroendoerinology, 2009, 90(2) : 167-183.

共引文献26

同被引文献54

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部